Shannon Moonah

Shannon Moonah, MD, ScM

Associate Professor Of Medicine | Physician-Scientist

Department: MD-INFECTIOUS DISEASES
Business Phone: (352) 273-7448
Business Email: shannonmoonah@ufl.edu

About Shannon Moonah

Shannon Moonah, MD, ScM, is a physician-scientist who attends in both inpatient and outpatient settings. Dr. Moonah has a special interest in intestinal health (infection, inflammation, & healing) and parasitology (gut protozoa). His research is supported by the National Institutes of Health (NIH), and Foundations such as the Robert Wood Johnson and Hartwell Foundations.

Dr. Moonah was born and raised in Jamaica, and for his residency, he came to the U.S. to train at Howard University in Washington, D.C, which included clinical and research electives at the NIH. He completed graduate training in molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health Malaria Research Institute, which was directed by Nobel Prize laureate Peter Agre, MD. Dr. Moonah followed this up by completing a four-year clinical and research-intensive NIH T32 fellowship program at the University of Virginia.

Accomplishments

Hartwell Foundation Investigator (PI), NIH R01 Award (PI), NIH R34 (Co-I), NIH K08 Physician-Scientist Award (PI), Robert Wood Johnson Foundation Harold Amos Scholar (PI).
2016-Current · NIH/Foundations
NIH Diversity Supplement Awardee
2016 · The goal of this supplement is to allow for the recruitment and retention of talented underrepresented minorities, and thereby enhance the biomedical workforce.

Teaching Profile

Courses Taught
2023
BMS6634 GI and Hepatology

Board Certifications

  • Infectious Diseases
    American Board of Internal Medicine (ABIM)
  • Internal Medicine
    American Board of Internal Medicine (ABIM)

Publications

2024
Selected Publications (below)
.
2023
Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy
Pediatrics. 152(3) [DOI] 10.1542/peds.2023-062307. [PMID] 37560802.
2023
Infection and inflammation stimulate expansion of a CD74+ Paneth cell subset to regulate disease progression
The EMBO Journal. [DOI] 10.15252/embj.2023113975.
2021
Acute appendicitis in four children with SARS-CoV-2 infection.
Journal of pediatric surgery case reports. 64 [DOI] 10.1016/j.epsc.2020.101734. [PMID] 33262930.
2021
Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent.
Frontiers in cellular and infection microbiology. 11 [DOI] 10.3389/fcimb.2021.633194. [PMID] 33777846.
2020
CD74 Signaling Links Inflammation to Intestinal Epithelial Cell Regeneration and Promotes Mucosal Healing.
Cellular and molecular gastroenterology and hepatology. 10(1):101-112 [DOI] 10.1016/j.jcmgh.2020.01.009. [PMID] 32004754.
2020
COP9 signalosome is an essential and druggable parasite target that regulates protein degradation.
PLoS pathogens. 16(9) [DOI] 10.1371/journal.ppat.1008952. [PMID] 32960936.
2020
Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair.
Frontiers in immunology. 11 [DOI] 10.3389/fimmu.2020.01273. [PMID] 32655566.
2019
Parasite-Produced MIF Cytokine: Role in Immune Evasion, Invasion, and Pathogenesis.
Frontiers in immunology. 10 [DOI] 10.3389/fimmu.2019.01995. [PMID] 31497025.
2019
Significance of amebiasis: 10 reasons why neglecting amebiasis might come back to bite us in the gut.
PLoS neglected tropical diseases. 13(11) [DOI] 10.1371/journal.pntd.0007744. [PMID] 31725715.
2019
Tissue Destruction Caused by Entamoeba histolytica Parasite: Cell Death, Inflammation, Invasion, and the Gut Microbiome.
Current clinical microbiology reports. 6(1):51-57 [DOI] 10.1007/s40588-019-0113-6. [PMID] 31008019.
2018
A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis.
Open forum infectious diseases. 5(7) [DOI] 10.1093/ofid/ofy161. [PMID] 30046644.
2018
The Impact of Systemic Inflammation on Neurodevelopment.
Trends in molecular medicine. 24(9):794-804 [DOI] 10.1016/j.molmed.2018.06.008. [PMID] 30006148.
2017
Entamoeba histolytica-Encoded Homolog of Macrophage Migration Inhibitory Factor Contributes to Mucosal Inflammation during Amebic Colitis.
The Journal of infectious diseases. 215(8):1294-1302 [DOI] 10.1093/infdis/jix076. [PMID] 28186296.
2017
Entamoeba Species in South Africa: Correlations With the Host Microbiome, Parasite Burdens, and First Description of Entamoeba bangladeshi Outside of Asia.
The Journal of infectious diseases. 216(12):1592-1600 [DOI] 10.1093/infdis/jix535. [PMID] 29236996.
2017
Microbiome-mediated neutrophil recruitment via CXCR2 and protection from amebic colitis.
PLoS pathogens. 13(8) [DOI] 10.1371/journal.ppat.1006513. [PMID] 28817707.
2016
Fulminant Amebic Colitis after Corticosteroid Therapy: A Systematic Review.
PLoS neglected tropical diseases. 10(7) [DOI] 10.1371/journal.pntd.0004879. [PMID] 27467600.
2013
Host immune response to intestinal amebiasis.
PLoS pathogens. 9(8) [DOI] 10.1371/journal.ppat.1003489. [PMID] 23990778.
2012
Burden of disease from cryptosporidiosis.
Current opinion in infectious diseases. 25(5):555-63 [DOI] 10.1097/QCO.0b013e328357e569. [PMID] 22907279.
.

Education

Clinical and Research Fellowship – Infectious Diseases, Intestinal Inflammation
2012-2016 · University of Virginia
ScM – Molecular Microbiology & Immunology
2010-2012 · Johns Hopkins School of Public Health
Residency, Internal Medicine (Assistant Chief, NIH Clinical and Research Electives)
2007-2010 · Howard University Hospital

Contact Details

Phones:
Business:
(352) 273-7448
Emails:
Addresses:
Business Street:
P.O. Box 100289
Division of Infectious Diseases & Global Medicine
GAINESVILLE FL 32611